Atlas Trials

The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study

Clinical trial NCT06806826 · COMPLETED

Trial details

NCT number
NCT06806826
Sponsor
Yuzuncu Yil University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Allergic Rhinitis
Start date
2019-01-01
Primary completion
2020-01-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.